{"id":"cofactor-anx-510","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"ANX-510 functions as a replacement for endogenous cofactors that are depleted or deficient in specific disease states, thereby restoring enzymatic function and metabolic pathways. This approach addresses the underlying biochemical defect rather than symptomatically treating disease manifestations. The drug is intended for conditions where cofactor deficiency is a primary pathogenic mechanism.","oneSentence":"CoFactor (ANX-510) is a cofactor replacement therapy designed to restore deficient cofactor levels in patients with certain metabolic or genetic disorders.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:06:34.126Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rare metabolic or genetic disorders associated with cofactor deficiency (specific indication not publicly detailed)"}]},"trialDetails":[{"nctId":"NCT07283900","phase":"PHASE2","title":"Ascorbate in Myelodysplastic Syndrome","status":"RECRUITING","sponsor":"Prajwal Dhakal","startDate":"2026-03-11","conditions":"Myelodysplastic Syndromes","enrollment":38},{"nctId":"NCT07393464","phase":"NA","title":"PQQ for Cognitive and Negative Symptoms","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Anding Hospital","startDate":"2026-02-15","conditions":"Schizophrenia, Cognitive Symptoms, Negative Symptoms","enrollment":70},{"nctId":"NCT04914845","phase":"PHASE1","title":"KPT-9274 in Patients With Relapsed and Refractory Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2021-08-27","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory","enrollment":16},{"nctId":"NCT04146376","phase":"","title":"Von Willebrand Factor in Pregnancy (VIP) Study","status":"RECRUITING","sponsor":"University of Washington","startDate":"2019-10-12","conditions":"Von Willebrand Diseases","enrollment":110},{"nctId":"NCT06273865","phase":"","title":"Version Testing of EnzySystem Version A for Hemophilia A","status":"SUSPENDED","sponsor":"Radboud University Medical Center","startDate":"2024-05-29","conditions":"Hemophilia A","enrollment":40},{"nctId":"NCT06377111","phase":"PHASE1","title":"A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-06-24","conditions":"Melanoma (Skin)","enrollment":12},{"nctId":"NCT05405309","phase":"PHASE1, PHASE2","title":"RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia","status":"TERMINATED","sponsor":"University of Utah","startDate":"2022-09-23","conditions":"Chronic Lymphocytic Leukemia","enrollment":5},{"nctId":"NCT06431113","phase":"PHASE3","title":"Effect of Fixed Combination Citicoline Homotaurine and Pyrroloquinoline Quinone on Pattern-electroretinogram in Glaucoma","status":"COMPLETED","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2024-01-27","conditions":"Glaucoma, Neuroprotection","enrollment":40},{"nctId":"NCT06418347","phase":"PHASE3","title":"Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-04-01","conditions":"Polycystic Ovary Syndrome, Infertility, Female","enrollment":150},{"nctId":"NCT06245083","phase":"EARLY_PHASE1","title":"Evaluating Pyrroloquinoline Quinone (PQQ) for Improving Obese Pregnancy Outcomes","status":"WITHDRAWN","sponsor":"University of Oklahoma","startDate":"2024-12","conditions":"Maternal Obesity","enrollment":""},{"nctId":"NCT04573153","phase":"PHASE2, PHASE3","title":"Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients","status":"TERMINATED","sponsor":"ScandiBio Therapeutics AB","startDate":"2020-09-21","conditions":"COVID-19","enrollment":100},{"nctId":"NCT04330326","phase":"PHASE2","title":"Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"ScandiBio Therapeutics AB","startDate":"2019-07-20","conditions":"Non-alcoholic Fatty Liver Disease (NAFLD)","enrollment":32},{"nctId":"NCT03527433","phase":"NA","title":"Comparing Wound Complications After Elective Abdominal Surgery Using Two Closure Techniques","status":"RECRUITING","sponsor":"American University of Beirut Medical Center","startDate":"2019-10-01","conditions":"Wound Complication","enrollment":274},{"nctId":"NCT06205095","phase":"PHASE3","title":"A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD","status":"RECRUITING","sponsor":"Unity Health Toronto","startDate":"2024-10-21","conditions":"Von Willebrand Diseases","enrollment":20},{"nctId":"NCT05720702","phase":"EARLY_PHASE1","title":"A Feasibility Trial of OCM Supplements for the Treatment of NAFLD","status":"COMPLETED","sponsor":"Duke University","startDate":"2023-06-30","conditions":"NAFLD","enrollment":31},{"nctId":"NCT06110598","phase":"PHASE2","title":"CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)","status":"WITHDRAWN","sponsor":"Case Comprehensive Cancer Center","startDate":"2024-12-01","conditions":"Pancreas Cancer, Pancreas Adenocarcinoma","enrollment":""},{"nctId":"NCT00243932","phase":"PHASE2","title":"Clinical Trial of High Dose CoQ10 in ALS","status":"COMPLETED","sponsor":"Columbia University","startDate":"2005-04","conditions":"Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease","enrollment":185},{"nctId":"NCT06253429","phase":"PHASE3","title":"Alpha-lipoic Acid in Diabetic Nephropathy","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-01-01","conditions":"Type 1 Diabetes","enrollment":30},{"nctId":"NCT02047461","phase":"PHASE2","title":"Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP","status":"COMPLETED","sponsor":"Origin Biosciences","startDate":"2014-04","conditions":"Molybdenum Cofactor Deficiency, Type A","enrollment":8},{"nctId":"NCT02629393","phase":"PHASE2, PHASE3","title":"Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A","status":"COMPLETED","sponsor":"Origin Biosciences","startDate":"2016-05","conditions":"Molybdenum Cofactor Deficiency, Type A","enrollment":5},{"nctId":"NCT05841303","phase":"PHASE4","title":"Comparative Evaluation of Vitamin C and Injectable-platelet Rich Fibrin in the Management of Thin Gingival Phenotype","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-07-01","conditions":"Thin Gingival Biotype","enrollment":13},{"nctId":"NCT04044131","phase":"PHASE2","title":"Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2019-12-02","conditions":"Alzheimer Disease, Parkinson Disease","enrollment":120},{"nctId":"NCT04823260","phase":"NA","title":"To Evaluate the Efficacy and Safety of NMN as an Anti-ageing Supplement in Middle Aged and Older (40-65 Years) Adults","status":"COMPLETED","sponsor":"Abinopharm, Inc","startDate":"2021-05-25","conditions":"Aging","enrollment":90},{"nctId":"NCT02836301","phase":"NA","title":"RCT- Comparing Testimonial Versus Documentary Organ Donation Video Education","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2015-05-21","conditions":"Organ Donation","enrollment":1440},{"nctId":"NCT02610153","phase":"","title":"Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-10-01","conditions":"Atrial Fibrillation","enrollment":1013},{"nctId":"NCT01894165","phase":"PHASE1","title":"Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers","status":"COMPLETED","sponsor":"Origin Biosciences","startDate":"2013-06","conditions":"Molybdenum Cofactor Deficiency (MoCD), Rare Autosomal Recessive Disorder, Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase)","enrollment":24},{"nctId":"NCT01735188","phase":"","title":"A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies","status":"COMPLETED","sponsor":"Origin Biosciences","startDate":"2013-08","conditions":"Molybdenum Cofactor Deficiency, Isolated Sulfite Oxidase Deficiency","enrollment":65},{"nctId":"NCT01640717","phase":"","title":"A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)","status":"COMPLETED","sponsor":"Origin Biosciences","startDate":"2012-11","conditions":"Molybdenum Cofactor Deficiency","enrollment":15},{"nctId":"NCT00202228","phase":"PHASE4","title":"Lactate Metabolism Study in HIV Infected Persons","status":"COMPLETED","sponsor":"Queen's University","startDate":"2002-07","conditions":"HIV Infections, AIDS, Lactic Acidosis","enrollment":30},{"nctId":"NCT00807391","phase":"NA","title":"Transbronchial Catheter Aspiration and Transbronchial Needle Aspiration in the Diagnosis of Lung Cancer","status":"COMPLETED","sponsor":"Helios Klinik Ambrock","startDate":"2009-07","conditions":"Lung Cancer","enrollment":48},{"nctId":"NCT00957749","phase":"PHASE1, PHASE2","title":"Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A","status":"WITHDRAWN","sponsor":"Orphatech Pharmaceuticals, GmbH","startDate":"2009-08","conditions":"Molybdenum Cofactor Deficiency Type A","enrollment":10},{"nctId":"NCT00663481","phase":"PHASE1","title":"A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects.","status":"COMPLETED","sponsor":"Mast Therapeutics, Inc.","startDate":"2008-04","conditions":"Healthy Adults","enrollment":15},{"nctId":"NCT00235898","phase":"PHASE2","title":"Clinical Trial in Patients With Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Mast Therapeutics, Inc.","startDate":"2005-05","conditions":"Colon Cancer, Rectal Cancer","enrollment":300},{"nctId":"NCT00434369","phase":"PHASE2","title":"5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients","status":"UNKNOWN","sponsor":"Mast Therapeutics, Inc.","startDate":"2006-02","conditions":"Breast Cancer","enrollment":31},{"nctId":"NCT00081627","phase":"PHASE2","title":"Clinical Trial in Patients With Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Mast Therapeutics, Inc.","startDate":"2004-04","conditions":"Colon Cancer, Rectal Cancer","enrollment":48},{"nctId":"NCT00337389","phase":"PHASE3","title":"Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.","status":"UNKNOWN","sponsor":"Mast Therapeutics, Inc.","startDate":"2006-05","conditions":"Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer","enrollment":1200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"CoFactor (ANX-510)","genericName":"CoFactor (ANX-510)","companyName":"Mast Therapeutics, Inc.","companyId":"mast-therapeutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CoFactor (ANX-510) is being studied in combination with alpha lipoic acid and letrozole for the treatment of Polycystic Ovary Syndrome in infertile females. It is also being investigated in clinical trials for other conditions, including melanoma, amyotrophic lateral sclerosis, and Lou Gehrig's disease, but the specific interventions and indications for these trials are not specified.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}